Branchenfonds • Branche: Gesundheit Aktien

Anlageschwerpunkt AZ Equity - Global Healthcare - B-AZ EUR ACC

WKN
ISIN
KVG
Azimut Investments S.A.
WKN
KVG
Azimut Investments S.A.
ISIN

KVG
4,135 EUR
-0,006 EUR-0,14 %
Geld
4,135 EUR
Brief
4,135 EUR
Werbung von onvista cashback
Jetzt Cashback für diesen Fonds berechnen!
Wir holen für dich die Verwaltungs­vergütungen beim Fonds­sparen zurück und zahlen dir die Bestands­provisionen, auch für bereits gekaufte Fonds, aus.

Fondsvolumen
89,88 Mio. EUR
Ausgabeaufschlag
Laufende Kosten
Morningstar-Rating
Ertrags­ver­wendung
Thesaurierend
Morningstar ESG-Rating

Zusammensetzung nach Branchen

Gesundheitswesen
Stand:
  • Gesundheitswesen (98,0 %)

Zusammensetzung nach Land

NordamerikaEuropaPazifik
Stand:
  • Nordamerika (84,0 %)
  • Europa (13,0 %)
  • Pazifik (2,0 %)

Zusammensetzung nach Instrument

Aktien
Stand:
  • Aktien (100,0 %)

Top Holdings zu AZ Equity - Global Healthcare - B-AZ EUR ACC

WertpapiernameAnteil
ELI LILLY & CO8,90 %
UNITEDHEALTH GROUP INC7,00 %
JOHNSON & JOHNSON5,10 %
ABBVIE INC4,60 %
NOVO NORDISK A/S-B4,50 %
THERMO FISHER SCIENTIFIC INC4,00 %
MERCK & CO. INC.4,00 %
ASTRAZENECA PLC3,90 %
NOVARTIS AG-REG3,00 %
BOSTON SCIENTIFIC CORP2,70 %
Summe:47,70 %
Stand:

Fondsstrategie zu AZ Equity - Global Healthcare - B-AZ EUR ACC

The Sub-fund's investment objective is to achieve long-term capital growth. The Sub-fund aims to achieve its investment objective by actively managing a diversified portfolio of equities issued by companies worldwide involved in the research, development, production and sale of pharmaceutical, medical and biomedical products. The Sub-fund invests directly or indirectly at least 80% of its net assets in equities issued by companies involved in the research, development, production and sale of pharmaceutical, medical and biomedical products. Indirect exposure is obtained by investing in derivatives based on equities and/or equity indices in order to adjust the overall exposure of the Sub-fund's portfolio. The Sub-fund may also invest up to 40% of its net assets in equities issued by companies headquartered and/or primarily doing business in an emerging market.